ProShares Supply Chain Logistics ETF (SUPL)
- Previous Close
40.16 - Open
38.78 - Bid 19.16 x 1200
- Ask 57.46 x 800
- Day's Range
38.36 - 38.36 - 52 Week Range
34.63 - 41.93 - Volume
22 - Avg. Volume
146 - Net Assets 2.03M
- NAV 38.43
- PE Ratio (TTM) --
- Yield 4.68%
- YTD Daily Total Return -4.94%
- Beta (5Y Monthly) 0.00
- Expense Ratio (net) 0.58%
The fund invests in financial instruments that ProShare Advisors believes should track the performance of the index. The index provider then selects into the index the 40 largest companies, by market capitalization, that generate 75% or more of their revenue from products or services produced or provided by one or more of the applicable RBICS Sub-Industries. The fund will invest at least 80% of its net assets in the securities that comprise the index. It is non-diversified.
ProShares
Fund Family
Industrials
Fund Category
2.03M
Net Assets
2022-04-06
Inception Date
Performance Overview: SUPL
Trailing returns as of 4/26/2024. Category is Industrials.
People Also Watch
Holdings: SUPL
Top 10 Holdings (45.94% of Total Assets)
Sector Weightings
Related ETF News
Research Reports: SUPL
Analyst Report: Anglo American plc
Anglo American's mining portfolio spans many commodities and continents. Like fellow large diversified miners, Anglo has significant exposure to copper, iron ore and metallurgical coal, but it is unique among the global majors given its significant platinum group metals and diamonds output. The company accounts for about one third of the world’s platinum supply and around 30% of palladium supply. Anglo also owns 85% of De Beers, in most years the world's largest supplier and marketer of rough gem diamonds by value. Anglo also plans to move back into the crop nutrients business via its Woodsmith polyhalite project in the United Kingdom.
RatingPrice TargetAnalyst Report: Amgen Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
RatingPrice TargetAnalyst Report: Honeywell International Inc.
Honeywell traces its roots to 1885 with Albert Butz’s firm, Butz-Thermo Electric Regulator, which produced a predecessor to the modern thermostat. Today, Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018. In 2019, the firm launched Honeywell Forge, its enterprise performance management software solution that leverages the firm's domain expertise in buildings, airlines, and critical infrastructure.
RatingPrice TargetAnalyst Report: 3M Company
3M is a multinational conglomerate that has operated since 1902 when it was known as Minnesota Mining and Manufacturing. The company is well-known for its research and development laboratory, and the firm leverages its science and technology across multiple product categories. As of 2020, 3M is organized into four business segments: safety and industrial, transportation and electronics, healthcare, and consumer. Nearly 50% of the company’s revenue comes from outside the Americas, with the safety and industrial segment constituting a plurality of the firm’s net sales. Many of the company’s 60,000-plus products touch and concern a variety of consumers and end markets.
RatingPrice Target